BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Deals

  Cerus to Participate In Upcoming Investor Conferences

  Cerus Corporation announced that the Company will participate in two upcoming investor conferences.

  February 22, 2019

   · 

  1 min read
• Business

  Canopy Growth Appoints Dr. Danial Schecter as Director, Global Medical Services

  Canopy Growth Corporation is pleased to announce the appointment of Dr. Danial Schecter as Director of Global Medical Services.

  February 22, 2019

   · 

  6 min read
• Biotech Bay

  Natera Announces Publication of Analytical Validation Study Demonstrating Superior Precision of Its Kidney Transplant Rejection Assay

  Core Technology Delivers Superior Analytical Performance, Underpins Outstanding Clinical Performance

  February 22, 2019

   · 

  8 min read
• Job Trends

  Celltex Therapeutics Corporation signs Memorandum of Understanding (MOU) with Saudi Arabia; expands presence to Riyadh

  Houston-based biotechnology company Celltex Therapeutics Corporation has entered a Memorandum of Understanding (MOU) with Saudi Arabia’s Research Products Development Company (RPDC) to support the commercialization of Celltex’s proprietary stem cell technology

  February 22, 2019

   · 

  3 min read
• Transcodent Article: How to Increase Patient Comfort During Dental Anesthetic Injections

  Patients expect different experiences from a visit to the dentist—a minty taste in their mouth, maybe a sticker on the way out—but when a needle is involved, those expectations can tend to be negative.

  February 22, 2019

   · 

  5 min read
• Department of Defense Tick-Borne Disease Research Program: Anticipated Funding Opportunities for Fiscal Year 2019 (FY19)

  The FY19 Defense Appropriation provides $5 million (M) to the Department of Defense Tick-Borne Disease Research Program (TBDRP) to support innovative, high-impact tick-borne disease research

  February 22, 2019

   · 

  3 min read
• Drug Development

  Faron Pharmaceuticals Ltd: MATINS study update

  Faron Pharmaceuticals Ltd (“Faron”) (LON: FARN), the clinical stage biopharmaceutical company, today announces an update on early observations on immunity and clinical response of MATINS patients post Clevegen administration.

  February 22, 2019

   · 

  8 min read
• Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases

  Calypso Biotech, an emerging leader in the development of therapeutic antibodies for autoimmune diseases, announces today the closing of a €20M Series A financing co-led by Gilde Healthcare and Inkef Capital.

  February 22, 2019

   · 

  5 min read
• Drug Development

  AlzProtect, on Track for a Phase 2 Entry in 2019, for its Drug Candidate AZP2006

  AlzProtect, a biopharmaceutical company engaged in the development of drugs for the treatment of Alzheimer’s disease and Progressive Supranuclear Palsy (PSP), announced today the successful completion of the latest phase 1 study regarding the effect of food intake for its drug candidate AZP2006.

  February 22, 2019

   · 

  3 min read
• Business

  WellCare Announces Appearances At Investor Conferences

  WellCare Health Plans, Inc. announced that members of its management team are scheduled to present at two upcoming conferences in March 2019.

  February 22, 2019

   · 

  1 min read